Skip to main content

JPMORGAN CHASE & CO

Position in RLMD — Relmada Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in RLMD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$271,284
+$268,223 QoQ
Shares Held
39,203
+668.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 126 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RLMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. RLMD ranks #219 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLMD

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $271,284 39,203
2025-06-30 $3,061 5,103
2025-03-31 $42 158
2024-12-31 $19,604 37,700
2024-09-30 $1,020,790 315,059
2024-06-30 $1,057,848 352,616
2024-03-31 $818,297 175,978
2023-12-31 $77,815 18,796
2023-09-30 $2,577 859
2023-06-30 $2,113 859
2023-03-31 $47,417 20,981
2022-12-31 $54,105 15,503
2022-09-30 $632,745 17,092
2022-06-30 $303,383 15,976
2022-03-31 $427,789 15,850
2021-12-31 $167,261 7,424
2021-09-30 $282,700 10,786
2021-06-30 $334,247 10,442
2021-03-31 $323,614 9,191
2020-12-31 $258,804 8,070
2020-09-30 $262,662 6,982
2020-06-30 $276,822 6,186